Triple

T10292043
Position Surface form Disambiguated ID Type / Status
Subject apixaban E241386 entity
Predicate substrateOf P37222 FINISHED
Object breast cancer resistance protein E241383 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: breast cancer resistance protein | Statement: [apixaban, substrateOf, breast cancer resistance protein]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: breast cancer resistance protein
Context triple: [apixaban, substrateOf, breast cancer resistance protein]
  • A. BCRP
    BCRP is the Central Reserve Bank of Peru, the country’s monetary authority responsible for maintaining monetary stability and managing its currency and international reserves.
  • B. BCRP chosen
    BCRP (Breast Cancer Resistance Protein) is an ATP-binding cassette (ABC) efflux transporter involved in multidrug resistance and the transport of various drugs and xenobiotics across cellular membranes.
  • C. P-glycoprotein
    P-glycoprotein is a membrane-bound efflux transporter protein that pumps various drugs and xenobiotics out of cells, influencing their absorption, distribution, and resistance profiles.
  • D. HER2 receptor
    The HER2 receptor is a cell surface protein and member of the epidermal growth factor receptor family that, when overexpressed, drives the growth of certain aggressive breast and other cancers.
  • E. ERBB2
    ERBB2, also known as HER2, is a receptor tyrosine kinase frequently overexpressed in certain breast and other cancers and serves as a key therapeutic target.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d381aaafc08190af475ef58dc16aba completed April 6, 2026, 9:49 a.m.
NER Named-entity recognition batch_69d4dfbfa26c8190b536655d33112ddf completed April 7, 2026, 10:43 a.m.
NED1 Entity disambiguation (via context triple) batch_69d71d1465e88190aaa8b295df3f9c8c completed April 9, 2026, 3:29 a.m.
Created at: April 6, 2026, 11:42 a.m.